Abnormalities of renal function have been recognised in virtually all acute and chronic liver and biliary diseases. Cirrhosis has received most attention and the abnormalities include renal failure, fluid retention, renal tubular acidosis and glomerulonephritis; ascites is common and may be renal in origin.
Renal failure
Between one half and three quarters of patients dying with cirrhosis show evidence of renal failure.1 2 In many cases this is merely part of the complex syndrome of terminal hepatic failure, and the patients die with rather than ofrenal failure. However, in one analysis of 253 patients the severity of the renal failure was out of proportion to the degree of hepatic impairment and was considered to be the main cause of death in 11%.3 Several distinct types of renal failure may occur in cirrhosis including hepatic nephropathy, failure due to diuretics and other drugs, and failure secondary to specific parenchymal diseases. HEPATIC Ascites with fluid retention is one of the commonest complications of cirrhosis. The relation between the formation of ascites and renal sodium excretion is of particular interest as the accumulation of ascites is always associated with sodium retention. Traditionally sodium retention has been considered as secondary to "effective"* blood or ECF volume depletion. Because of ascites formation extracellular fluid is lost into the peritoneal cavity. Simultaneously, because of portal hypertension, blood is sequestered in the splanchnic circulation. Both of these result in a fall of renal perfusion and hence in stimulation of the renin-angiotensin-aldosterone system which causes sodium retention. Thus the sodium retention is held to be a homeostatic mechanism to maintain the interstitial fluid and blood volumes. However, many recent findings are not in keeping with this concept, at least for the majority of patients. In particular renal perfusion is often normal or even increased.3536 Furthermore renin and aldosterone concentrations are not increased in about two-thirds of patients accumulating ascites.37-40 Despite this, there is considerable evidence that aldosterone is a major factor in the regulation of renal sodium excretion in cirrhosis. Firstly, a close correlation can be shown between plasma aldosterone concentrations and sodium excretion.38 Secondly, the aldosterone antagonist spironolactone will almost invariably reverse the fluid retention.38 41 Finally in a study of the effect of 3-adrenergic blockade, sodium excretion was found to change exactly as predicted by the changes in aldosterone, as the latter decreased or increased.42 There may even be an increased renal tubular sensitivity to aldosterone, as has been proposed for dogs with constriction of the thoracic inferior vena cava, a model with many similarities to cirrhosis with ascites.43 If this is so, it may be the mechanism whereby sodium retention is initiated in cirrhosis. Ascites might then develop in accordance with *The term depletion of "effective" blood volume (or ECF volume) was introduced to "explain" the occurrence, in patients whose blood volume is normal or even high, of circulatory and hormonal changes that are associated with a low blood volume. Thus, it is really the effectiveness of the blood volume in maintaining homeostasis that is reduced.-Eds.
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Lieberman's "overflow" concept,44 according to which the fluid retained by the kidney is preferentially localised to the peritoneal cavity as ascites because of the presence of portal hypertension and reduced plasma oncotic pressure45-that is, ascites is secondary to sodium retention rather than its cause. However, one-third of such patients do have increased values of the components of the reninangiotensin-aldosterone system so that in them it is possible that ascites formation does occur according to the traditional concept.
